Aparna Srikantam

605 total citations
26 papers, 297 citations indexed

About

Aparna Srikantam is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Aparna Srikantam has authored 26 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 17 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Aparna Srikantam's work include Mycobacterium research and diagnosis (15 papers), Tuberculosis Research and Epidemiology (13 papers) and Leprosy Research and Treatment (9 papers). Aparna Srikantam is often cited by papers focused on Mycobacterium research and diagnosis (15 papers), Tuberculosis Research and Epidemiology (13 papers) and Leprosy Research and Treatment (9 papers). Aparna Srikantam collaborates with scholars based in India, United Kingdom and Germany. Aparna Srikantam's co-authors include Dzung B. Diep, Christian Kranjec, Arghya Das, Khalid Hussain Bhat, Sangita Mukhopadhyay, Kirill V. Ovchinnikov, Svenja Steinfelder, Patrick M. Tarwater, Susanne Hartmann and Richard Lucius and has published in prestigious journals such as Scientific Reports, Annals of the New York Academy of Sciences and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

Aparna Srikantam

24 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aparna Srikantam India 10 188 122 81 68 39 26 297
Julian Ye China 10 180 1.0× 102 0.8× 70 0.9× 58 0.9× 69 1.8× 22 333
Zorica Vasiljević Serbia 12 56 0.3× 95 0.8× 132 1.6× 62 0.9× 22 0.6× 27 420
Amirhooshang Alvandi Iran 12 130 0.7× 93 0.8× 154 1.9× 142 2.1× 11 0.3× 56 438
Hüseyin Güdücüoğlu Türkiye 9 73 0.4× 109 0.9× 73 0.9× 29 0.4× 38 1.0× 52 289
Lúcia Helena Vitali Brazil 8 154 0.8× 180 1.5× 59 0.7× 15 0.2× 14 0.4× 14 396
Naglaa Mohamed United States 12 154 0.8× 80 0.7× 136 1.7× 25 0.4× 23 0.6× 31 446
Maneesh Paul‐Satyaseela United States 13 104 0.6× 112 0.9× 117 1.4× 61 0.9× 34 0.9× 24 449
Paul M. Luethy United States 11 158 0.8× 135 1.1× 99 1.2× 80 1.2× 61 1.6× 31 510
M. Ruiz Spain 10 358 1.9× 308 2.5× 111 1.4× 114 1.7× 19 0.5× 23 544
Ay Huey Huang Taiwan 9 114 0.6× 93 0.8× 54 0.7× 55 0.8× 74 1.9× 10 311

Countries citing papers authored by Aparna Srikantam

Since Specialization
Citations

This map shows the geographic impact of Aparna Srikantam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aparna Srikantam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aparna Srikantam more than expected).

Fields of papers citing papers by Aparna Srikantam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aparna Srikantam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aparna Srikantam. The network helps show where Aparna Srikantam may publish in the future.

Co-authorship network of co-authors of Aparna Srikantam

This figure shows the co-authorship network connecting the top 25 collaborators of Aparna Srikantam. A scholar is included among the top collaborators of Aparna Srikantam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aparna Srikantam. Aparna Srikantam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasker, Epco, Emmanuelle Cambau, Annemieke Geluk, et al.. (2025). Interrupting transmission of Mycobacterium leprae: synthesis of new evidence and research recommendations. Leprosy Review. 96(2).
2.
Kukkaro, Petra, Sundeep Chaitanya Vedithi, David J. Blok, et al.. (2024). Target product profiles: leprosy diagnostics. Bulletin of the World Health Organization. 102(4). 288–295. 6 indexed citations
3.
4.
Iyer, Venkateswaran K., Neena Malhotra, Urvashi B. Singh, et al.. (2021). Immunohistochemical evaluation of infiltrating immune cells in endometrial biopsy of female genital tuberculosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 267. 174–178. 1 indexed citations
5.
Kranjec, Christian, et al.. (2021). A bacteriocin-based treatment option for Staphylococcus haemolyticus biofilms. Scientific Reports. 11(1). 13909–13909. 24 indexed citations
6.
Kranjec, Christian, et al.. (2020). A bacteriocin-based antimicrobial formulation to effectively disrupt the cell viability of methicillin-resistant Staphylococcus aureus (MRSA) biofilms. npj Biofilms and Microbiomes. 6(1). 58–58. 42 indexed citations
7.
Srikantam, Aparna, et al.. (2020). Comorbidities associated with non- healing of plantar ulcers in leprosy patients. PLoS neglected tropical diseases. 14(6). e0008393–e0008393. 11 indexed citations
8.
Tarwater, Patrick M., et al.. (2020). Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India. PLoS neglected tropical diseases. 14(10). e0008678–e0008678. 26 indexed citations
9.
Srikantam, Aparna, et al.. (2020). Occurrence of bacterial biofilm in leprosy plantar ulcers. Leprosy Review. 91(2). 130–138. 3 indexed citations
10.
Lambert, Saba M., Aparna Srikantam, Joydeepa Darlong, et al.. (2019). Three drugs are unnecessary for treating paucibacillary leprosy—A critique of the WHO guidelines. PLoS neglected tropical diseases. 13(10). e0007671–e0007671. 9 indexed citations
11.
Babu, Subash, Ralf R. Schumann, Aparna Srikantam, et al.. (2018). Association of a PD-L2 Gene Polymorphism with Chronic Lymphatic Filariasis in a South Indian Cohort. American Journal of Tropical Medicine and Hygiene. 100(2). 344–350. 3 indexed citations
12.
Srikantam, Aparna, et al.. (2016). Molecular analysis of Rv0679c and Rv0180c genes of Mycobacterium tuberculosis from clinical isolates of pulmonary tuberculosis. Indian Journal of Medical Microbiology. 34(4). 471–475. 1 indexed citations
13.
Srikantam, Aparna, et al.. (2016). Assessment of Sputum Quality and Its Importance in the Rapid Diagnosis of Pulmonary Tuberculosis. 8(4). 15 indexed citations
14.
Steinfelder, Svenja, et al.. (2014). Brugia malayi Microfilariae Induce a Regulatory Monocyte/Macrophage Phenotype That Suppresses Innate and Adaptive Immune Responses. PLoS neglected tropical diseases. 8(10). e3206–e3206. 32 indexed citations
15.
Steinfelder, Svenja, et al.. (2014). Filariasis asymptomatically infected donors have lower levels of disialylated IgG compared to endemic normals. Parasite Immunology. 36(12). 713–720. 12 indexed citations
16.
Bhat, Khalid Hussain, Arghya Das, Aparna Srikantam, & Sangita Mukhopadhyay. (2013). PPE2 protein of Mycobacterium tuberculosis may inhibit nitric oxide in activated macrophages. Annals of the New York Academy of Sciences. 1283(1). 97–101. 30 indexed citations
17.
18.
Srikantam, Aparna, et al.. (2009). In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India. Transactions of the Royal Society of Tropical Medicine and Hygiene. 103(6). 564–570. 8 indexed citations
19.
Srikantam, Aparna, et al.. (2008). A study of mycobacterial species causing lymphadenitis.. PubMed. 39(1). 130–5. 5 indexed citations
20.
Srikantam, Aparna, et al.. (2008). MYCOBACTERIAL CULTURE OF FINE NEEDLE ASPIRATE - A USEFUL TOOL IN DIAGNOSING TUBERCULOUS LYMPHADENITIS. Indian Journal of Medical Microbiology. 26(3). 259–261. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julian Ye Breakdown of academic impact, for papers by Zorica Vasiljević Breakdown of academic impact, for papers by Amirhooshang Alvandi Breakdown of academic impact, for papers by Hüseyin Güdücüoğlu Breakdown of academic impact, for papers by Lúcia Helena Vitali Breakdown of academic impact, for papers by Naglaa Mohamed Breakdown of academic impact, for papers by Maneesh Paul‐Satyaseela Breakdown of academic impact, for papers by Paul M. Luethy Breakdown of academic impact, for papers by M. Ruiz Breakdown of academic impact, for papers by Ay Huey Huang
Rankless by CCL
2026